Asset Details
Do you wish to reserve the book?
Plasma neuropeptides as circulating biomarkers of multifactorial schizophrenia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Plasma neuropeptides as circulating biomarkers of multifactorial schizophrenia
Do you wish to request the book?
Plasma neuropeptides as circulating biomarkers of multifactorial schizophrenia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Plasma neuropeptides as circulating biomarkers of multifactorial schizophrenia
2019
Overview
Promising biomarkers would be used to improve the determination of diagnosis and severity, as well as the prediction of symptomatic and functional outcomes of schizophrenia.
In this study, we used three different mouse models induced by a genetic factor (PV-Cre; ErbB4−/−, G group), an environmental stressor (adolescent social isolation, G group), and a combination of genetic factor and environmental stressor (PV-Cre; ErbB4−/− mice with isolation, G × E group). Attenuated PPI (%) confirmed the successful establishment of three schizophrenia-like mouse models. To evaluate whether neuropeptide levels in plasma would be potential biomarkers of different schizophrenia models in our work, we used MILLIPLEX® MAP method to simultaneously measure 6 critical neuropeptides in plasma.
Among the evaluated neuropeptides, increased neurotensin tends to be associated with genetic factors of schizophrenia, increased orexin A seems to be a biomarker of an interplay between genetic and social isolation, while higher plasma oxytocin might be more apt to be responsive to social isolation. The potential biomarkers are mostly independent of sex.
This research would provide novel clues to develop circulating biomarkers of plasma neuropeptides for multifactorial schizophrenia.
•Both genetic and environmental factors were considered for the schizophrenia models.•Six neuropeptides were simultaneously measured using only 250 μL sample.•Different neuropeptides might be responsive to specific pathological factors.•Novel clues to develop circulating biomarkers for multifactorial schizophrenia
